The Latest Cardiac and Vascular News
ANAHEIM, Calif.–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that it has been awarded a group purchasing agreement for the Chest Drainage Products category with Premier. Effective July 15th 2018, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and […]
WAYNE, Pa.–(BUSINESS WIRE)–Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Wells Fargo Securities 2018 Healthcare Conference at the Westin Copley Place in Boston, MA, Wednesday, September 5, 2018 at 4:10 p.m. (ET). A live audio webcast of the conference presentation, along with the […]
PHOENIX, Aug. 21, 2018 (GLOBE NEWSWIRE) — (OTCQB:SNWV) — SANUWAVE Health, Inc.’s Chairman and CEO, Kevin Richardson, Returns to Uptick Newswire’s “Stock Day” Podcast to report on a 300% increase in revenue. The interview began with Jolly noting, “You know, you guys knocked it out of the park. You just […]
Santa Monica, CA, Aug. 20, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that it has partnered with Mrs. Amy Ansfield Scott in order […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today announced the appointment of industry leader, Jeb Keiper, as an independent member of its Board of Directors. Mr. Keiper joins founder Michael Mendelsohn, M.D., Ken Novack, Ed Mascioli, […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that it has appointed Jeffrey S. Brown as the Company’s Chief Operations Officer, effective as of August 13, 2018. John Onopchenko, Chief Executive Officer of Endologix, Inc., said, “I […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–BioAxone BioSciences, Inc., a biotechnology company focused on developing innovative drugs to treat neurotrauma and neurovascular disorders, today announced that its Scientific Advisory Board member, Dr. Mark Bear, the Picower Professor of Neuroscience at the Massachusetts Institute of Technology, received the prestigious Arnold and Mabel Beckman Foundation 2018 Beckman-Argyros […]
SAN CLEMENTE, Calif., Aug. 14, 2018 /PRNewswire/ — ROX Medical, Inc. (ROX), a privately held medical device company pioneering a minimally-invasive therapy for hypertension, today announced the appointment of Mike MacKinnon as its Chief Executive Officer. “Despite the many classes of drugs available to physicians to treat hypertension, millions of patients still have blood pressures […]
REDWOOD CITY, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the second quarter ended June 30, 2018. Second Quarter and Recent Highlights Revenue of $2.1 million for the second quarter of 2018, […]
LOS ANGELES–(BUSINESS WIRE)–Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its second quarter and six months ended June 30, 2018, after the closing of the stock market on Tuesday, August 14, 2018. The Company […]
